Milestone Scientific (MLSS) vs Stereotaxis (STXS)
Head-to-head comparison of performance, valuation, growth, profitability and dividends. Prices delayed 15 minutes; data as of Oct 9, 2026.
Summary
Milestone Scientific (MLSS) has outperformed Stereotaxis (STXS) over the past year, losing 23.4% versus a loss of 68.9%. Over five years, STXS leads with a -81.3% price change compared with -82.9% for MLSS. Stereotaxis is the larger company by market cap ($109.4 million vs $34.0 million), about 3.2 times the size.
Summary generated from market data by MetaCap's automated system. Methodology
Relative performance
Percent change in share price from the first common trading day shown; excludes dividends.
Head-to-head
| Metric | MLSS | STXS |
|---|---|---|
| Share price | $0.3751 | $1.09 |
| Market cap | $33.99M | $109.35M |
| 1-day change | +4.19% | -1.68% |
| YTD return | +33.33% | -51.74% |
| 1-year return | -23.40% | -68.91% |
| 5-year return | -82.94% | -81.28% |
| EPS (TTM) | $-0.04 | $-0.24 |
| Dividend yield | 0.00% | 0.00% |
| Annual dividend | $0.00 | $0.00 |
| 52-week high | $0.58 | $3.42 |
| 52-week low | $0.22 | $1.09 |
| Distance from 52-week high | -35.33% | -68.09% |
| Analyst consensus | none | none |
| Avg. price target upside | +233.24% | +174.90% |
| Average volume | 128.06K | 808.41K |
| Shares outstanding | 90.61M | 100.20M |
| Employees | 15 | 131 |
| Sector | Health Care | Health Care |
| Industry | Industrial Specialties | Biotechnology: Electromedical & Electrotherapeutic Apparatus |
Highlighted cells mark the higher value for growth, returns, margins and yield, and the lower value for P/E ratios. Highlighting is a mechanical comparison, not a recommendation.
Key differences
- Stereotaxis is about 3.2 times larger than Milestone Scientific by market value ($109.35M vs $33.99M).
- MLSS has outperformed STXS by 45.5 percentage points over the past year.
About Milestone Scientific
MLSS stock →Milestone Scientific Inc., a biomedical technology company, patents, designs, develops, and commercializes diagnostic and therapeutic injection technologies, and devices for medical and dental use in the United States, China, and internationally. It operates through Dental and Medical segments.
Health Care · Industrial Specialties · 15 employees
About Stereotaxis
STXS stock →Stereotaxis, Inc. designs, manufactures, and markets robotic systems, instruments, and information systems for the interventional laboratory in the United States and internationally.
Health Care · Biotechnology: Electromedical & Electrotherapeutic Apparatus · 131 employees
MLSS vs STXS FAQ
Which is bigger, Milestone Scientific or Stereotaxis?
Stereotaxis (STXS) is larger, with a market capitalization of $109.35M compared with $33.99M for Milestone Scientific (MLSS).
Which stock has performed better over the past year, MLSS or STXS?
MLSS returned -23.40% over the past 12 months, compared with -68.91% for STXS (price return, excluding dividends). Past performance does not predict future results.
Are Milestone Scientific and Stereotaxis in the same industry?
Both are in the Health Care sector, but in different industries: Industrial Specialties for Milestone Scientific and Biotechnology: Electromedical & Electrotherapeutic Apparatus for Stereotaxis.